BRAF V600E mutant oligodendroglioma-like tumors with chromosomal instability in adolescents and young adults.


Journal

Brain pathology (Zurich, Switzerland)
ISSN: 1750-3639
Titre abrégé: Brain Pathol
Pays: Switzerland
ID NLM: 9216781

Informations de publication

Date de publication:
05 2020
Historique:
received: 03 07 2019
accepted: 11 10 2019
pubmed: 21 10 2019
medline: 9 7 2021
entrez: 21 10 2019
Statut: ppublish

Résumé

We performed genome-wide methylation analysis on 136 pediatric low-grade gliomas, identifying a unique cluster consisting of three tumors with oligodendroglioma-like histology, BRAF p.V600E mutations and recurrent whole chromosome gains of 7 and loss of 10. Morphologically, all showed similar features, including a diffusely infiltrative glioma composed of round nuclei with perinuclear halos, a chicken-wire pattern of branching capillaries and microcalcification. None showed astrocytic features or characteristics suggestive of high-grade tumors including necrosis or mitotic figures. All tumors harbored multiple chromosomal copy number abnormalities (>10 chromosomes altered), but none showed 1p/19q co-deletion or IDH1 p.R132H mutation. Hierarchical clustering and t-stochastic neighbor embedding analyses from DNA methylation data cluster them more closely to previously described pediatric-type low-grade gliomas and separate from adult gliomas. These tumors exhibit distinct clinical features; they are temporal lobe lesions occurring in adolescents and young adults with a prolonged history of seizures and all are alive with no recurrence (follow-up 3.2 to 13.2 years). We encountered another young adult case with quite similar pathological appearance and molecular status except for TERT promoter mutation. Although the series is small, these may represent a new category of IDH wild-type low-grade gliomas which may be confused with "molecular GBM." Further, they highlight the heterogeneity of IDH wild-type gliomas and the relatively indolent behavior of "pediatric-type" gliomas.

Identifiants

pubmed: 31630459
doi: 10.1111/bpa.12799
pmc: PMC8018140
doi:

Substances chimiques

BRAF protein, human EC 2.7.11.1
Proto-Oncogene Proteins B-raf EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

515-523

Subventions

Organisme : Tokyo Children's Cancer Study Group (TCCSG) scholarship of the Gold Ribbons Network of Japan
Pays : International
Organisme : RESTRACOMP of the Hospital for Sick Children
Pays : International
Organisme : Canadian Institute of Health Research (CIHR) CGS-M scholarship
Pays : International
Organisme : Ontario Graduate Scholarship (OGS)
Pays : International
Organisme : A Kids' Brain Tumor Cure Foundation
Pays : International

Informations de copyright

© 2019 International Society of Neuropathology.

Références

Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Nat Genet. 2013 Aug;45(8):927-32
pubmed: 23817572
J Clin Oncol. 2017 Jul 20;35(21):2394-2401
pubmed: 28640702
Cancer Cell. 2018 May 14;33(5):829-842.e5
pubmed: 29763623
Neuro Oncol. 2017 Oct 1;19(10):1327-1337
pubmed: 28575485
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Cell. 2016 Jan 28;164(3):550-63
pubmed: 26824661
Nat Genet. 2015 May;47(5):458-68
pubmed: 25848751
J Neuropathol Exp Neurol. 2017 Jul 1;76(7):562-570
pubmed: 28863456
Epigenetics. 2013 Feb;8(2):203-9
pubmed: 23314698
Neuro Oncol. 2010 Jul;12(7):621-30
pubmed: 20156809
Cancer Cell. 2014 Aug 11;26(2):288-300
pubmed: 25117714
Nat Genet. 2013 Jun;45(6):602-12
pubmed: 23583981
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Neuro Oncol. 2018 Jan 10;20(1):66-77
pubmed: 29016839
Acta Neuropathol. 2017 Dec;134(6):957-959
pubmed: 29052002
J Clin Oncol. 2015 Mar 20;33(9):1015-22
pubmed: 25667294
Acta Neuropathol. 2018 Nov;136(5):805-810
pubmed: 30259105
Acta Neuropathol. 2017 Mar;133(3):417-429
pubmed: 27812792
J Clin Oncol. 2017 Sep 1;35(25):2934-2941
pubmed: 28727518
Acta Neuropathol Commun. 2016 Aug 31;4(1):93
pubmed: 27577993
Bioinformatics. 2017 Feb 15;33(4):558-560
pubmed: 28035024

Auteurs

Kohei Fukuoka (K)

Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.

Yasin Mamatjan (Y)

Princess Margaret Cancer Centre and MacFeeters, Hamilton Centre for Neuro-Oncology Research, Toronto, ON, Canada.

Scott Ryall (S)

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

Martin Komosa (M)

Program in Genetics and Genome Biology, The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.

Julie Bennett (J)

Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.

Michal Zapotocky (M)

Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.

Julia Keith (J)

Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Sten Myrehaug (S)

Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Lili-Naz Hazrati (LN)

Division of Pathology, The Hospital for Sick Children, Toronto, ON, Canada.

Kenneth Aldape (K)

Princess Margaret Cancer Centre and MacFeeters, Hamilton Centre for Neuro-Oncology Research, Toronto, ON, Canada.

Norm Laperriere (N)

Department of Radiation Oncology, Princess Margaret Hospital, Toronto, ON, Canada.

Eric Bouffet (E)

Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.

Uri Tabori (U)

Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.

Cynthia Hawkins (C)

Division of Pathology, The Hospital for Sick Children, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH